INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 60 filers reported holding INOTEK PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $11,000 | -21.4% | 4,444 | -45.4% | 0.00% | – |
Q3 2017 | $14,000 | +27.3% | 8,144 | +24.1% | 0.00% | – |
Q2 2017 | $11,000 | +22.2% | 6,560 | +27.4% | 0.00% | – |
Q1 2017 | $9,000 | -92.7% | 5,150 | -74.6% | 0.00% | – |
Q4 2016 | $123,000 | -60.6% | 20,291 | -38.8% | 0.00% | – |
Q3 2016 | $312,000 | +155.7% | 33,165 | +98.1% | 0.00% | – |
Q2 2016 | $122,000 | -43.8% | 16,743 | -43.1% | 0.00% | – |
Q1 2016 | $217,000 | -35.0% | 29,433 | -0.5% | 0.00% | – |
Q4 2015 | $334,000 | +255.3% | 29,585 | +195.8% | 0.00% | – |
Q3 2015 | $94,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
FT Options LLC | 26,421 | $299,000 | 0.22% |
EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |